OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected to start before the end of Hilary Term to allow all future events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed on the Staff Gateway and via email to identified OxTalks users.
If you have any questions, please contact halo@digital.ox.ac.uk
Cannabidiol is being investigated as a novel treatment for both psychosis and cannabis use disorder. There is also evidence from experimental studies in healthy volunteers that is can reduce the acute adverse effects of cannabis intoxication. In this talk, Dr Chesney will describe a randomised placebo controlled trial investigating if a large oral dose of CBD can reduce the adverse effects of vaporised cannabis in individuals with schizophrenia and schizoaffective disorder.
zoom.us/j/97234106780?pwd=OEtUaDJsS3UrUklhZHRyOFVDK3p0Zz09
Meeting ID: 972 3410 6780
Passcode: 004054
